Professional Documents
Culture Documents
Medical-Management (1) Final
Medical-Management (1) Final
MEDICAL MANAGEMENT
LDH Date Ordered: The lactate dehydrogenase (LDH) The LDH test is used to identify 158 U/L 208-414 U/L
September 20, laboratory test includes examining tissue damage, keep track of
2023
blood samples to determine the conditions that cause tissue damage,
Date Results
concentrations of LDH, an and assess the therapeutic effect of
September 20,
enzyme present in many human chemotherapy.
2023
tissues. This test is frequently LDH levels are monitored in diseases
monitoring of diseases.
HBsAG Date Ordered: Hepatitis B surface antigen, often The presence of HBsAg indicates NONREACTIVE
September 19, known as HBsAg, is a protein that that the person is infectious, except
2023
may be seen on the hepatitis B when it might be transiently positive
Date Results
virus's surface. A person has an within 30 days after a dose of
September 19,
2023 active hepatitis B infection if hepatitis B vaccine (HepB). The
RPR Date Ordered: The RPR (Rapid Plasma Reagin) RPR (Rapid Plasma Reagin) testing NONREACTIVE
September 19, test is a diagnostic method for detects syphilis by identifying anti-
2023
syphilis, a sexually transmitted cardiolipin antibodies in the blood,
Date Results
infection, to be detected. It indicating an active infection. During
September 19,
2023 functions by identifying blood the test, blood is mixed with a
A urinalysis provides a wide The following are the variety of Physical pH: 4.5-8
Date Ordered:
Urinalysis spectrum of data from which components of the urinalysis to be Examination: mean 6
September 21,
2023 tentative diagnoses can be made. evaluated: • Color Specific
(10:35 PM) The urinalysis may indicate the Dark Yellow gravity:
be trace in
Sugar • RBC normal
None negative
Epithelial Cells
• Albumin Microscopic
Mucus Threads
Trace sediment:
A. Urates
• Sugar Crystals: little
A. Phosphate
Negative significance
Crystals:
• Bile Test Casts: more
Calcium oxalates
None are
Uric Acid
• Ketones pathological
Bacteria in the urine
None (some hyaline
Bacteria in the urine
• Epithelial Cells casts normal)
Uncontrolled diabetes, starvation
Moderate RBCs:
Tumor, calculus, occasional less
• Crystals: than 2-3 per
glomerulonephritis high power.
• Calcium oxalate
Infection
Kidney disease None
None
• T. Vaginalis
Bacteria
None
Hematology Date Ordered The Complete Blood Count outpatient and inpatient basic • Hemoglobin for adults:
Test:
September 20, (CBC) is a combination report of screening and diagnostic test that 128 g/L
Complete Blood 2023 • Hemoglobin
Count a series of tests of the peripheral provides information about the • WBC ct.
Date Result F: 120-160 g/L
blood. The quantity, percentage, hematological system and many 10.1
September 20, • WBC
2023 variety, concentrations, and other systems. It is used in routine • Bleeding Time 4-10
quality of blood cells are physical examination and in the 2 “00” Differential
identified. The tests usually diagnosis of a wide range of • Clotting Time Count:
included in a CBC are hematocrit, conditions and diseases of children 4 “00” • Neutrophils
hemoglobin, red cell count, red and adults (note: refer to individual Differential 55-65%
blood cell indices, white cell tests for a specific clinical Count: • Lymphocytes
0.00 M: 0.40-0.50
0.39 F: 4.0-5.4
4.32
• Platelet Count
Normal Values
or screening test that analyzes his diagnostic test provides a device • FBS • FBS
Analyte test Date Ordered: specific compounds or for determining the concentration of None 74- 106 mg/dl
September
20,2023 components in a patient's an analyte like glucose, cholesterol,
biological sample, such as blood, free fatty acids, triglycerides, • BUN S.I.
(11:00 AM)
urine, or tissue. These tests are proteins, ketones, phenylalanine or None 4.1-5.9 mmol/L
Date Results in:
performed to evaluate a patient's enzymes, in a physiological or • Creatinine • BUN
September 20,
2023 health, diagnose medical aqueous fluid like blood, serum, 0.5 M: 9-20 mg/dl
disorders, monitor disease plasma, saliva, urine, interstitial S.I. F: 7-17 mg/dl
development, or evaluate the and/or intra-cellular fluid, the device 46.0 S.I.
None F: 62.106
• Sodium umol/L
None • UA
None mg/dl
None S.I.
None umol/L
F: 149-369
umol/L
• Cholesterol
S.I
<5.2 mmol/L
• Glycerife
<150 mg/dl
S.I
1.7 mmol/L
• TDL
> 40 mg/dl
S.I
• SGOT
M: 17-59 u/L
F: 14-36 u/L
• SGPT
M: 21-72 u/L
F: 9-52 u/L
• Amylase
30-110 mmol/L
• CKMB
Up to 16 u/L
• Sodium
135-148
mmol/L
• Potassium
3.5-5.3 mmol/L
• Chloride
98-107
Nursing Care and Responsibilities (LDH):
Before test
Explain the test procedure and the purpose of the test to the patient. Assess their knowledge of
the test. Prepare the equipment and supplies needed. If a consent form is required, the nurse
should prepare it. If the patient’s guardian asks questions, provide information about the
During Test
Adhere to standard precautions or sterile technique if necessary. The nurse should provide
emotional support to the patient; and monitor the patient’s response during the procedure. Ensure
After test
Apply pressure to the venipuncture site. Explain that some bruising, discomfort, and
swelling may appear at the site and that warm, moist compresses can alleviate this. Monitor for
signs of infection. In this period, nursing care revolves around observations and follow-up
activities for the patient. Report the results to the physician (or the appropriate members of the
*The nurse must also consider that infants and children will need assistance in remaining still
during the venipuncture and age-appropriate comfort measures following the test.
Before test
Explain the test procedure and the purpose of the test to the patient. Assess their knowledge of
the test. Prepare the equipment and supplies needed. If a consent form is required, the nurse
should prepare it. If the patient’s guardian asks questions, provide information about the
Adhere to standard precautions or sterile technique if necessary. The nurse should provide
emotional support to the patient; and monitor the patient’s response during the procedure. Ensure
After test
Apply pressure to the venipuncture site. Explain that some bruising, discomfort, and
swelling may appear at the site and that warm, moist compresses can alleviate this. Monitor for
signs of infection. In this period, nursing care revolves around observations and follow-up
activities for the patient. Report the results to the physician (or the appropriate members of the
*The nurse must also consider that infants and children will need assistance in remaining still
during the venipuncture and age-appropriate comfort measures following the test.
Before test
Explain the test procedure and the purpose of the test to the patient. Assess their knowledge of
the test. Prepare the equipment and supplies needed. If a consent form is required, the nurse
should prepare it. If the patient’s guardian asks questions, provide information about the
During Test
Adhere to standard precautions or sterile technique if necessary. The nurse should provide
emotional support to the patient; and monitor the patient’s response during the procedure. Ensure
After test
Apply pressure to the venipuncture site. Explain that some bruising, discomfort, and
swelling may appear at the site and that warm, moist compresses can alleviate this. Monitor for
signs of infection. In this period, nursing care revolves around observations and follow-up
activities for the patient. Report the results to the physician (or the appropriate members of the
*The nurse must also consider that infants and children will need assistance in remaining still
during the venipuncture and age-appropriate comfort measures following the test.
Before test
Explain the test procedure and the purpose of the test to the patient. Assess their knowledge of
the test. Prepare the equipment and supplies needed. If a consent form is required, the nurse
should prepare it. If the patient’s guardian asks questions, provide information about the
During Test
discarded or contaminated with feces, discard entire specimen, and begin the test again.
After test
*The nurse must also consider a collection bag or insertion of a straight catheter is likely
Before test
Explain the test procedure and the purpose of the test to the patient. Assess their knowledge of
the test. Prepare the equipment and supplies needed. If a consent form is required, the nurse
should prepare it. If the patient’s guardian asks questions, provide information about the
During test
Adhere to standard precautions or sterile technique if necessary. The nurse should provide
emotional support to the patient; and monitor the patient’s response during the procedure. Ensure
After test
Apply pressure to the venipuncture site. Explain that some bruising, discomfort, and swelling
may appear at the site and that warm, moist compresses can alleviate this. Monitor for signs of
infection. In this period, nursing care revolves around observations and follow-up activities for
the patient. Report the results to the physician (or the appropriate members of the health care
team).
*The nurse must also consider that infants and children will need assistance in remaining still
during the venipuncture and age-appropriate comfort measures following the test.
Before test
Explain the test procedure and the purpose of the test to the patient. Assess their knowledge of
the test. Prepare the equipment and supplies needed. If a consent form is required, the nurse
should prepare it. If the patient’s guardian asks questions, provide information about the
emotional support to the patient; and monitor the patient’s response during the procedure.
After test
Apply pressure to the venipuncture site. Explain that some bruising, discomfort, and swelling
may appear at the site and that warm, moist compresses can alleviate this. Monitor for signs of
infection. In this period, nursing care revolves around observations and follow-up activities for
the patient. Report the results to the physician (or the appropriate members of the health care
team).
*The nurse must also consider that infants and children will need assistance in remaining still
during the venipuncture and age-appropriate comfort measures following the test.
B. IVF, THERAPY, DRUGS ETC.
Date
Route of
Administration Dosage
Ordered
Medical and Frequency of
Administration General Description Indication or Purpose Client’s Response
Management Date
Started
Date Changed
Route of Administration: Hydralazine is used to treat high blood Hydralazine is an antihypertensive
Date Ordered:
Intravenous IV
pressure (hypertension). It is also used agent used for the management of
Fluid Infusion September 20,
2023
to control high blood pressure in a essential hypertension or severe
Hydralazine Dosage: 5mg
Date Started
mother during pregnancy (pre- hypertension associated with conditions
September 20,
2023 Frequency of eclampsia or eclampsia) or in requiring immediate action, heart
Administration:
emergency situations when blood failure, and pre-eclampsia or eclampsia.
Date
Date Changed
Intravenous Date Ordered: Route of Administration: Normal saline is a cornerstone of This intravenous solution is indicated
Fluid Infusion
September 20, IV intravenous solutions commonly used in
for use in adults and pediatric patients
Saline Solution: 2023
the clinical setting. It is a crystalloid
mgSay 4g dicuk as a source of electrolytes and water for
in 50 cc PNSS Date Started Dosage: 4g fluid administered via an intravenous
5Iup
hydration. Also, designed for use as a
Septemb solution. Its indications are sources of
er 20, Frequency of hydration and electrolyte disturbances. diluent and delivery system for
2023 Administration: It can come in various concentrations; intermittent intravenous administration
that have been approved by the FDA: catheter area after you have received an
hemorrhage, sepsis)
Date Changed
Date Ordered: Route of Administration: N/A
Intravenous Dexamethasone accelerates maturation Dexamethasone is a corticosteroid,
Fluid Infusion September 20, IM
2023 of fetal lungs, decreases number of which is a type of drug. It is commonly
Dexamethasone
Date Started Dosage: 6mg: 4 doses neonates with respiratory distress used to treat inflammation and edema in
September 20, syndrome and improves survival in the body. It can be administered
2023
Frequency of
preterm delivered neonates. Optimal throughout pregnancy to assist prevent
Administration:
gestational age for use of preterm delivery by encouraging fetal
C.MEDICATIONS
Date
Date
Changed
Date Ordered: Date Ordered: Methyldopa is a centrally acting
Methyldopa Methyldopa can help reduce
September 20, September 20, 2023 alpha-2 adrenergic agonist used to
250 mg
2023 pregnancy issues such as
manage hypertension alone or in
Date Started
Date Started combination with hypertension (high blood pressure)
September 20, 2023
Septem hydrochlorothiazide, and to treat and a related disease known as pre-
ber 20,
eclampsia. Preterm birth, low birth
2023 hypertensive crises.
weight in the newborn, and illness in
Methyldopa crosses the placenta and
both the mother and the baby, which
may cause mild hypotension in
D. DIET
Type of Diet Date General Description Indication/ Purpose Specific Foods Taken Client’s Response
Ordered
Date
Started
Date
Change
d
Diet as Date Diet as tolerated is "Diet as tolerated" is a meal plan that Foods allowed include broiled,
tolerated Ordere frequently prescribed is frequently provided to patients in baked, or boiled trimmed
Septemb Individuals are only hospitals or after surgery. It indicates without skin, nonfat and low-
er 20, provided liquids such as that the patient should eat or drink fat milk products, fruits and
2023 water once a surgical according to their comfort and ability vegetables, most breads,
operation is completed. to do so without causing discomfort, pastas, rice, caffeine, and salt
finally, a conventional
gastrointestinal tract is
Zumba and yoga can help regulate It protects against preeclampsia and
Recreational Physical Activities
blood pressure. Properly managed other hypertensive illnesses by
provider's guidance.
References
https://www.ncbi.nlm.nih.gov/books/NBK551671/#:~:text=Methyldopa%20is%20a
%20medication%20used,in%20the%20management%20of%20hypertension.
https://healthfully.com/205546-what-is-the-meaning-of-diet-as-tolerated.html
Lab Tests Online. (2021). LDH: The Test. American Association for Clinical Chemistry.
https://labtestsonline.org/tests/ldh
dehydrogenase-ldh-test/#:~:text=An%20LDH%20test%20is%20most,and%20some
%20types%20of%20infections.
World Health Organization. (2017). Guidelines on hepatitis B and C testing. World Health
Organization. https://www.who.int/hepatitis/publications/guidelines-hepatitis-c-b-
testing/en/
detailed.htm